i reading month journal clinical psychiatry came across dimension psychiatrist pharmaceutical company dynamic rarely object analysis i ca put ad appears copyrighted i describe see graphic picture man brown pullover sweater middle hands pressed together concerned look looks toward younger man slightly unkempt right younger man staring away making eye contact far left behind counter woman wearing white coat protective gloves swirls erlenmeyer flask containing bluish liquid theory mind says man middle psychiatrist man right patient woman kind biomedical researcher copy reads challenges challenges alkermes inspired challenges psychiatrists face every day share dedication patients living schizophrenia depression addiction develop new treatments begin compassionate understanding real world needs stand ready improve health patients i sure psychiatrists see advertising would suggested alkermes take less melodramatic approach alkermes relatively new cns pharmaceuticals drugs pipeline schizophrenia depression many addiction psychiatrists used seeing version long acting naltrexone called vivitrol i never seen sales representative company pharmaceutical company reps taken hit new anti pharma religion banned clinics hospitals academic settings area rap essentially influencing physicians prescribe products financial incentives form gifts many cases personal relationships combination secondary issue pharma associated educational activities less well disguised advertising number forms new approach alkermes taps area psychiatrists i previously seen area focus basically saying beleaguered physicians understand side although seems like clumsy first attempt message powerful senior psychiatrist practiced long i realize apart good colleagues might time time nobody side many psychiatrists professionally isolated may see colleagues annual meeting others larger organizations mismanaged point colleagues seen competition rather resources nobody side professionally attempts treat patients fact i illustrated many people way try provide care patients incentivized get ration care many cases comes providing care alkermes approach captures least part unconscious reason affiliating oneself friendly entity guess whoever behind understanding going physicians psychiatrists particular pharmaceutical company ad never make explicit also asymmetry relationship discussing bundling cost pharmaceutical product much effective way get reimbursed bundling cost form psychiatrist even though appear feel pain really george dawson md dfapa supplementary breaking news patent office aripiprazole lauroxil patent app covers methods treating schizophrenia mania bipolar disorder anxiety depression administering broad class compounds including aripiprazole lauroxil alks patent app covers composition matter alks patent app covers attenuation weight gain associated olanzapine patients schizophrenia administering combination samidorphan formerly alks olanzapine alks patent app covers composition matter full details read press release alkermes web site